IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons With HIV
Seroprotection rate increased from 94.4 percent at eight weeks after second dose to 98.5 percent at week 24
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.